Embody review
Advertises low headline compounded GLP-1 prices, then quotes different figures across three funnels behind countdown timers and a promotional discount.
- Semaglutide
- From $79/mo (promo-dependent)
- Tirzepatide
- From $129/mo (promo-dependent)
- Coverage
- 48 states
- Brand-name
- Compounded only
The scorecard
Embody scored on our six published factors. See the methodology.
What we like
- Low advertised compounded rates: from $79 a month for semaglutide injection and from $129 a month for tirzepatide injection
- Names four partner pharmacies on the homepage: RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx
- Offers oral formulations as well as injections, including a compounded oral tirzepatide gum
- States that 'Your price does not increase if your dose changes within the same medication'
- Medical leadership is named: Dr Alan Viglione, board-certified in internal medicine, with 24/7 clinician messaging included
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved, and compounded oral tirzepatide has no FDA-approved counterpart at all
- Three of the company's own funnels quoted three different prices on the same day, one behind a countdown timer warning of an imminent increase
- The advertised rate depends on an auto-applied promotion rather than list pricing, and reviewers allege the 'locked' rate has not always been honored
- Your card is charged at checkout before the eligibility consult, and a full refund applies only if you are disqualified or the medication is undispensed
- Not available in Louisiana or Mississippi, contrary to the all-fifty-states claim carried elsewhere
The verdict
Best for: A price-led buyer who will read the terms carefully and can accept that the advertised rate depends on a promotion rather than on list pricing. Advertises low headline compounded GLP-1 prices, then quotes different figures across three funnels behind countdown timers and a promotional discount.
Ranked #397 of 539 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. In the ranking it sits between Aspen at #396, 57/100 above and Nolu at #398, 57/100 below, with the Boston Medical Group ruling the next one down.
Weighing it against something else? Every provider we would put in front of Embody is ranked on price honesty, prescriber access and cancellation terms.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs Embody goes to CoreAge Rx, 94/100 to 57/100.
Compare with other providers
The closest rulings to Embody by Verdict Score — the realistic shortlist if you are weighing this one up.
- #392Push Health— Push Health is a large US telehealth platform that routes brand-name GLP-1 prescriptions (Ozempic, Zepbound, Mounjaro) through a 55,000+ pharmacy network.58/100
- #393T2D.com— T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.58/100
- #394Walgreens Weight Management— Walgreens virtual care program offering compounded GLP-1 medications through its retail pharmacy network.58/100
- #395Sunlight— A no-quiz FAQ answer states both molecule prices up front, but the homepage's own "injections and oral options" claim names an oral product the rest of the site never prices or names again.55/100
- #396Aspen— Publishes every price tier before intake, but its 'monthly' plan bills three months upfront, the provider picks your molecule, and Mississippi and Louisiana are excluded.57/100
- #398Nolu— An all-in per-order price with a rare oral route — but every figure on the site is billed per 4 weeks, not by the calendar month.57/100
Pricing, states and verification reflect Embody's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Embody's site. Not medical advice; see our disclosure.